Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Overview of attention for article published in this source, October 1985

Altmetric Badge

Mentioned by

policy: 1 policy source

patent: 19 patents

Citations

dimensions_citation: 2738 Dimensions

Readers on

mendeley: 280 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 19 patents that reference this research output.

SEQUENTIAL TREATMENTS AND BIOMARKERS TO REVERSE RESISTANCE TO KINASE INHIBITORS

Application WO-2023067058-A1

World Intellectual Property Organisation (WIPO)

METHODS AND KITS FOR PREDICTING THE EFFICACY OF MIDOSTAURIN FOR THE TREATMENT OF CANCER

Application WO-2022243679-A2

World Intellectual Property Organisation (WIPO)

Sequential treatments and biomarkers to reverse resistance to kinase inhibitors

Grant GB-202115017-D0

United Kingdom

Methods of treating myelodysplastic syndromes with a combination therapy using…

Grant US-11116782-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 15 additional patents.